Moreover, the overexpression of ZNF667-AS1 resulted in decreased invasion and migration rates of colon cancer cells, whereas treatment with transforming growth factor β1 (TGF-β1) resulted in increased invasion and migration rates of the same cancer cells. Here, ZNF667 is linked to malignant colon neoplasm.